Development of PEGylated PLGA nanoparticle for controlled and sustained drug delivery in cystic fibrosis

Abstract

We have developed a novel drug delivery system to provide sustained delivery of CF "correctors" and "anti-inflammatories" to the lungs. Moreover, we demonstrate here the therapeutic efficacy of nano-based proteostasis-modulator to rescue Pa-LPS induced CF lung disease.